195 related articles for article (PubMed ID: 15199385)
1. Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer.
Ahmed N; Barker G; Oliva KT; Hoffmann P; Riley C; Reeve S; Smith AI; Kemp BE; Quinn MA; Rice GE
Br J Cancer; 2004 Jul; 91(1):129-40. PubMed ID: 15199385
[TBL] [Abstract][Full Text] [Related]
2. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
[TBL] [Abstract][Full Text] [Related]
3. Proteomic identification of fucosylated haptoglobin alpha isoforms in ascitic fluids and its localization in ovarian carcinoma tissues from Mexican patients.
Garibay-Cerdenares OL; Hernández-Ramírez VI; Osorio-Trujillo JC; Hernández-Ortíz M; Gallardo-Rincón D; Cantú de León D; Encarnación-Guevara S; Villegas-Pineda JC; Talamás-Rohana P
J Ovarian Res; 2014 Feb; 7():27. PubMed ID: 24576319
[TBL] [Abstract][Full Text] [Related]
4. Identification of ovarian cancer-associated proteins in symptomatic women: A novel method for semi-quantitative plasma proteomics.
Shield-Artin KL; Bailey MJ; Oliva K; Liovic AK; Barker G; Dellios NL; Reisman S; Ayhan M; Rice GE
Proteomics Clin Appl; 2012 Apr; 6(3-4):170-81. PubMed ID: 22532453
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of serum biomarkers of ovarian epithelial cancers based on 2-DE DIGE and MALDI TOF/TOF].
Zhao Q; Duan W; Wu YM; Qian XH; Deng XH
Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):754-8. PubMed ID: 19173805
[TBL] [Abstract][Full Text] [Related]
6. Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas.
Hamrita B; Chahed K; Trimeche M; Guillier CL; Hammann P; Chaïeb A; Korbi S; Chouchane L
Clin Chim Acta; 2009 Jun; 404(2):111-8. PubMed ID: 19306859
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometric identification, characterization and validation of the haptoglobin β-chain protein as a lung cancer serum biomarker.
Ayyub A; Saleem M; Musharraf SG; Naz M; Tariq A; Hashmi N
Mol Med Rep; 2015 Sep; 12(3):3755-3762. PubMed ID: 26005016
[TBL] [Abstract][Full Text] [Related]
8. An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum.
Ahmed N; Barker G; Oliva K; Garfin D; Talmadge K; Georgiou H; Quinn M; Rice G
Proteomics; 2003 Oct; 3(10):1980-7. PubMed ID: 14625860
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of haptoglobin within ovarian cyst fluid as a potential point-of-care test for epithelial ovarian cancer: an observational study.
Mahyuddin AP; Liu L; Zhao C; Kothandaraman N; Salto-Tellez M; Pang B; Lim D; Annalamai L; Chan J; Lim T; Biswas A; Rice G; Razvi K; Choolani M
BJOG; 2018 Mar; 125(4):421-431. PubMed ID: 28755436
[TBL] [Abstract][Full Text] [Related]
11. Proteomic identification of serum biomarkers for gastric cancer using multi-dimensional liquid chromatography and 2D differential gel electrophoresis.
Liu W; Liu B; Cai Q; Li J; Chen X; Zhu Z
Clin Chim Acta; 2012 Jul; 413(13-14):1098-106. PubMed ID: 22446497
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of proteomics-identified CCL18 and CXCL1 as circulating tumor markers for differential diagnosis between ovarian carcinomas and benign pelvic masses.
Wang Q; Li D; Zhang W; Tang B; Li QQ; Li L
Int J Biol Markers; 2011; 26(4):262-73. PubMed ID: 21928244
[TBL] [Abstract][Full Text] [Related]
13. Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry.
Ye B; Cramer DW; Skates SJ; Gygi SP; Pratomo V; Fu L; Horick NK; Licklider LJ; Schorge JO; Berkowitz RS; Mok SC
Clin Cancer Res; 2003 Aug; 9(8):2904-11. PubMed ID: 12912935
[TBL] [Abstract][Full Text] [Related]
14. Differentially expressed serum haptoglobin alpha chain isoforms with potential application for diagnosis of head and neck cancer.
Chen CB; Su YC; Huang TT; Ho HC; Chang YT; Tung YT; Lee WC
Clin Chim Acta; 2008 Dec; 398(1-2):48-52. PubMed ID: 18727923
[TBL] [Abstract][Full Text] [Related]
15. Identification of transgelin as a potential novel biomarker for gastric adenocarcinoma based on proteomics technology.
Huang Q; Huang Q; Chen W; Wang L; Lin W; Lin J; Lin X
J Cancer Res Clin Oncol; 2008 Nov; 134(11):1219-27. PubMed ID: 18446369
[TBL] [Abstract][Full Text] [Related]
16. Proteomic-based analysis for identification of potential serum biomarkers in gallbladder cancer.
Tan Y; Ma SY; Wang FQ; Meng HP; Mei C; Liu A; Wu HR
Oncol Rep; 2011 Oct; 26(4):853-9. PubMed ID: 21687958
[TBL] [Abstract][Full Text] [Related]
17. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
[TBL] [Abstract][Full Text] [Related]
18. Biomarker discovery in breast cancer serum using 2-D differential gel electrophoresis/ MALDI-TOF/TOF and data validation by routine clinical assays.
Huang HL; Stasyk T; Morandell S; Dieplinger H; Falkensammer G; Griesmacher A; Mogg M; Schreiber M; Feuerstein I; Huck CW; Stecher G; Bonn GK; Huber LA
Electrophoresis; 2006 Apr; 27(8):1641-50. PubMed ID: 16550499
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer.
Jones MB; Krutzsch H; Shu H; Zhao Y; Liotta LA; Kohn EC; Petricoin EF
Proteomics; 2002 Jan; 2(1):76-84. PubMed ID: 11788994
[TBL] [Abstract][Full Text] [Related]
20. Proteomic identification of tumor biomarkers associated with primary gallbladder cancer.
Huang HL; Yao HS; Wang Y; Wang WJ; Hu ZQ; Jin KZ
World J Gastroenterol; 2014 May; 20(18):5511-8. PubMed ID: 24833881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
